Concepedia

Akihisa Kaneko

AK

14

Publications

495

Citations

11

H-Index

1989

Active since

Affiliations

Chugai Pharma (United States)(Current)

Tokyo University of Science

Akihisa Kaneko is an author at Chugai Pharma (United States) specializing in medicine, radiation oncology, and pharmacology.

ORCID

Top concepts

Publications per year

1989–2022

14

Publications

14

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 195 citations

A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor

Tetsuro Orita, Hiroyuki Tsunoda, Naohiro Yabuta et al. · Blood · 2004 · 67 citations · Full text

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 54 citations · Full text

The Novel Pig In Vitro Maturation System to Improve Developmental Competence of Oocytes Derived from Atretic Nonvascularized Follicles

Asako Okamoto, Maki Ikeda, Akihisa Kaneko et al. · Biology of Reproduction · 2016 · 28 citations

<i>In vitro</i>model for the prediction of clinical CYP3A4 induction using HepaRG cells

Akihisa Kaneko, Motohiro Kato, Nobuo Sekiguchi et al. · Xenobiotica · 2009 · 23 citations

Rows per page

1–5 of 14